GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HBM Holdings Ltd (FRA:6XY) » Definitions » Price-to-Free-Cash-Flow

HBM Holdings (FRA:6XY) Price-to-Free-Cash-Flow : 27.18 (As of May. 23, 2025)


View and export this data going back to 2021. Start your Free Trial

What is HBM Holdings Price-to-Free-Cash-Flow?

As of today (2025-05-23), HBM Holdings's share price is €1.06. HBM Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.04. Hence, HBM Holdings's Price-to-Free-Cash-Flow Ratio for today is 27.18.

The historical rank and industry rank for HBM Holdings's Price-to-Free-Cash-Flow or its related term are showing as below:

FRA:6XY' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 6.8   Med: 23.37   Max: 30.07
Current: 27.48

During the past 7 years, HBM Holdings's highest Price-to-Free-Cash-Flow Ratio was 30.07. The lowest was 6.80. And the median was 23.37.

FRA:6XY's Price-to-Free-Cash-Flow is ranked better than
54.67% of 225 companies
in the Biotechnology industry
Industry Median: 31.09 vs FRA:6XY: 27.48

HBM Holdings's Free Cash Flow per Share for the six months ended in Dec. 2024 was €-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €0.04.

During the past 7 years, HBM Holdings's highest 3-Year average Free Cash Flow per Share Growth Rate was 47.70% per year. The lowest was -56.40% per year. And the median was -27.90% per year.


HBM Holdings Price-to-Free-Cash-Flow Historical Data

The historical data trend for HBM Holdings's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HBM Holdings Price-to-Free-Cash-Flow Chart

HBM Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - 6.14

HBM Holdings Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 6.14

Competitive Comparison of HBM Holdings's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, HBM Holdings's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HBM Holdings's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HBM Holdings's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where HBM Holdings's Price-to-Free-Cash-Flow falls into.


;
;

HBM Holdings Price-to-Free-Cash-Flow Calculation

HBM Holdings's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1.06/0.039
=27.18

HBM Holdings's Share Price of today is €1.06.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. HBM Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

HBM Holdings  (FRA:6XY) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


HBM Holdings Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of HBM Holdings's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


HBM Holdings Business Description

Traded in Other Exchanges
Address
218 Xinghu Street, Suite 202, Building A3, Suzhou Industrial Park, Suzhou, CHN, 215123
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. The majority of the revenue for the firm is generated from the United States.

HBM Holdings Headlines

No Headlines